Market Research Logo

Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Viamet Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Viamet Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Viamet Pharmaceuticals, Inc.
  • The report provides overview of Viamet Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Viamet Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Viamet Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Viamet Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Viamet Pharmaceuticals, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Viamet Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Viamet Pharmaceuticals, Inc. Snapshot
Viamet Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Viamet Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Viamet Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Viamet Pharmaceuticals, Inc. - Pipeline Products Glance
Viamet Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Viamet Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Viamet Pharmaceuticals, Inc. - Drug Profiles
VT-1161
Product Description
Mechanism of Action
R&D Progress
VT-1129
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Orphan Diseases
Product Description
Mechanism of Action
R&D Progress
VT-1598
Product Description
Mechanism of Action
R&D Progress
VT-1607
Product Description
Mechanism of Action
R&D Progress
VT-1654
Product Description
Mechanism of Action
R&D Progress
VT-1658
Product Description
Mechanism of Action
R&D Progress
VT-1669
Product Description
Mechanism of Action
R&D Progress
VT-1681
Product Description
Mechanism of Action
R&D Progress
Viamet Pharmaceuticals, Inc. - Pipeline Analysis
Viamet Pharmaceuticals, Inc. - Pipeline Products by Target
Viamet Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Viamet Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Viamet Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Viamet Pharmaceuticals, Inc. - Recent Pipeline Updates
Viamet Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Viamet Pharmaceuticals, Inc., Key Information
Viamet Pharmaceuticals, Inc., Key Facts
Viamet Pharmaceuticals, Inc. - Pipeline by Indication, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Viamet Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Viamet Pharmaceuticals, Inc. - Phase II, 2016
Viamet Pharmaceuticals, Inc. - Phase I, 2016
Viamet Pharmaceuticals, Inc. - Preclinical, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Target, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Viamet Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Viamet Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016
List of Figures
Viamet Pharmaceuticals, Inc. - Pipeline by Indication, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Viamet Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Target, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Viamet Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Viamet Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report